ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors
Phase 4
- Conditions
- Non Functioning Pancreatic Endocrine Tumor
- Interventions
- Biological: Chromogranin A
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 111
- Registration Number
- NCT02759718
Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and Splenectomy
Phase 4
Completed
- Conditions
- Benign Neoplasm of Body of PancreasBenign Neoplasm of Tail of Pancreas
- Interventions
- Device: 3-dimensional distal pancreatectomyDevice: 2-dimensional distal pancreatectomy
- First Posted Date
- 2016-05-02
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02757690
Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma
- First Posted Date
- 2016-04-27
- Last Posted Date
- 2016-04-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT02753062
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer
Phase 2
Completed
- Conditions
- Pancreatic Adenocarcinoma
- Interventions
- Drug: Preoperative modified FOLFIRINOX and postoperative gemcitabine
- First Posted Date
- 2016-04-22
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT02749136
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma
Phase 2
- Conditions
- Treatment ResponseFeasibilityAdverse Events
- Interventions
- Procedure: Photodynamic therapy
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-04-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT02725073
- Locations
- 🇰🇷
Do Hyun Park, Seoul, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
Phase 2
Completed
- Conditions
- Gastrointestinal Stromal Tumors (GISTs)
- Interventions
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 51
- Registration Number
- NCT02712112
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation
Phase 4
Completed
- Conditions
- Mitral Valve InsufficiencyLeft Ventricular Dysfunction
- Interventions
- First Posted Date
- 2016-02-22
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 118
- Registration Number
- NCT02687932
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Yonsei University Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
Phase 2
Terminated
- Conditions
- NeutropeniaFebrile NeutropeniaBreast Cancer
- Interventions
- First Posted Date
- 2016-02-18
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT02685111
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)
- First Posted Date
- 2015-12-14
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 268
- Registration Number
- NCT02629510
- Locations
- 🇰🇷
Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of
Brain Glioma Registry Combining Clinical and Imaging Information
Recruiting
- Conditions
- Adult Glioma
- Interventions
- Other: Brain Glioma Registry
- First Posted Date
- 2015-12-02
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 9000
- Registration Number
- NCT02619890
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath